Total Funding
$12M
Employee Range
11-50
Endolytix develops innovative therapies to combat antibiotic resistance in NTM infections. Their approach targets intrinsic resistance, offering new solutions for effective treatment.
Endolytix data powered by:
Share
Endolytix data powered by:
EndolytixOverall Ranking
National Rank
Share
Loading...
In United States
Top null%out of startups
Regional Rank
Share
Loading...
In North America
Top null%out of startups
EndolytixIndustry Rankings in
Healthtech
City Rank
Share
4th
In Beverly
Top 37%out of 11 startups
National Rank
Share
3,810th
In United States
Top 43%out of 8869 startups
Regional Rank
Share
4,025th
In North America
Top 42%out of 9671 startups
EndolytixSubindustry Rankings in
Health CareCity Rank
Share
1st
In Beverly
Top 34%out of 3 startups
National Rank
Share
1,608th
In United States
Top 40%out of 4101 startups
Regional Rank
Share
1,707th
In North America
Top 39%out of 4449 startups
rankings by:
EndolytixSB Rank Evolution
Not enough data points to display the chart.
EndolytixstartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro